Skip to main content
. 2022 Apr 27;13:861583. doi: 10.3389/fimmu.2022.861583

Figure 2.

Figure 2

Composition of sEVs from lungs, heart and kidney transplant patients. (A) Col-V and Kα1T TAgs on lung specific sEVs (B) MYO and VIM TAgs on heart specific sEVs (C) Perlecan and Fibronectin TAgs on kidney specific sEVs.